Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symphony: Solifenacin + Mirabegron in OAB
NCT01340027Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Mar 2011
- Primary completion
- Jun 2012
- Modality
- Orthosteric Ligands
- Countries
- 20
01
Overview
A Phase 2 trial of mirabegron, solifenacin in overactive bladder (OAB), sponsored by Astellas Pharma. Started Mar 2011; status: completed.
02
Drugs
mirabegronsolifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT01340027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01340027.